Source: Annual Congress 2005 - Applied physiology in clinical practice
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
E. Kolarzyk, D. Pach, J. Chrostek-Maj (Krakow, Poland). Breathing regulation of opiate dependent patients before and after 5 years of methadone maintenance treatment. Eur Respir J 2005; 26: Suppl. 49, 4347

Member's Comments

No comment yet.

Related content which might interest you: Effect of treatment for nicotine dependence using bupropion therapy in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 283s Year: 2007 Does chronic opioid use impact OSA diagnosis and response to treatment with CPAP? Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects Year: 2020 Sleep disordered breathing in patients receiving therapy with buprenorphine/naloxone Source: Eur Respir J 2013; 42: 394-403 Year: 2013 Do symptomatic asthmatic smokers need a higher maintenance dose when treated with budesonide/formoterol maintenance and reliever therapy than non-smokers? Source: Annual Congress 2010 - Combination therapy in asthma and COPD Year: 2010 Bupropion hydrochloride sustained release (SR) is an effective and well tolerated aid to smoking cessation in smokers with cardiovascular disease. 12 month follow-up phase data (ZYB40014) Source: Eur Respir J 2002; 20: Suppl. 38, 611s Year: 2002 Characteristics of patients treated with nicotine replacement therapy (NRT) prescribed during hospitalization Source: International Congress 2019 – Tobacco cessation interventions in different settings and populations Year: 2019 Effect of ICS withdrawal on COPD exacerbations in patients on triple therapy at baseline Source: International Congress 2018 – COPD management Year: 2018 Variation of regular maintenance therapy with budesonide/formoterol of children with asthma Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma Year: 2008 Increased mortality rate associated with prescribed opioid medications: is there a link with sleep disordered breathing? Source: Eur Respir J 2005; 26: Suppl. 49, 596s Year: 2005 Reslizumab reduces severe exacerbations associated with emergency department visit or hospitalization and improves measures of lung function in patients on maintenance oral corticosteroids (OCS) at baseline Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017 Increase in health status after 12 days treatment with inhaled mannitol in patients with bronchiectasis Source: Eur Respir J 2003; 22: Suppl. 45, 430s Year: 2003 Less than 20% of COPD patients persist with long-acting inhaled drugs for at least three years Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Impact of morning symptoms experienced by COPD patients on exacerbation risk, rescue inhaler usage and normal daily activities Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 Budesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma Source: Eur Respir J, 51 (1) 1701688; 10.1183/13993003.01688-2017 Year: 2018 Effectiveness of a cognitive orientation program with and without nicotine replacement therapy in stopping smoking in hospitalised patients Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment Year: 2011 Growth deceleration of children on inhaled corticosteroids is compensated for after the first 12 months of treatment Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007 Influence of age on evolution of asthma control level and treatment compliance under ICS/LABA therapy Source: Eur Respir J 2005; 26: Suppl. 49, 382s Year: 2005 The influence of smoking on the treatment response in patients with asthma Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients Year: 2007 COPD exacerbation: resolution of symptoms after starting antibiotic treatment was unaltered by the timing of therapy but was dependent on baseline gas transfer Source: Annual Congress 2008 - Management of COPD Year: 2008 Budesonide/formoterol for maintenance and relief vs. higher dose ICS/LABA therapy: outcomes in patients symptomatic on high-dose inhaled corticosteroids (HDICS) Source: Annual Congress 2007 - Recent advances in our understanding of the mechanisms of asthma treatment Year: 2007